Table 1.
Reference | Type of study; location | Number of subjects | Age | Number of patients with visible ocular findings | RT-PCR results for SARS-CoV-2 | Day of symptom presentation (if noted) | Symptomology and physical exam findings | Treatments (if noted) | Other important findings |
---|---|---|---|---|---|---|---|---|---|
Wu et al. [4] | Retrospective case series; Hubei province, China | 38 (28 confirmed COVID+) | Mean 65.8 | 12 out of 38 (31.6%) | 2 positive for both C and NP swabs | Not noted | Conjunctival hyperemia, chemosis, epiphora, or increased secretions | ||
Guan et al. [10] | 30 provinces in China | 1099 | Median 47 | 9 (0.8%) | All confirmed positive on NP swab | Not noted | Conjunctival congestion | ||
Loffredo et al. [16] | Meta-analysis of 3 studies; China | 1167 | 47–68 | 1.1% | In 2 studies, 3 out 68 had positive C swab | Not noted | Conjunctivitis | Patients with severe COVID-19 had increased incidence of conjunctivitis (P = 0.030) | |
Abrishami et al. [17] | Cross-sectional, observational study; Northeastern Iran | 142 | Mean 62.6 (range 23–96) | 69 | 77 positive on NP swab | None detected as presenting complaint |
Complaints included tearing, erythema, irritation, itching, foreign body sensation, periorbital pain, photophobia, and blurred vision On external exam, erythema and conjunctival swelling noted On SLE, conjunctival hyperemia and chemosis were noted |
||
Poddar et al. [18] | Case report | 1 | 65 | 1 | Positive on NP swab | Day 7 after admission, day 30 after symptom onset | Unilateral conjunctival congestion with severe follicular reaction on lower palpebral conjunctiva with conjunctival prolapse | Lubricants and prophylactic preservative-free moxifloxacin 0.5% | Hyperemia resolved in 5 days; follicles resolved after 2 weeks |
Seah et al. [22] | Prospective case study; Singapore | 17 | Median 37 (range 20–75) | 1 | All confirmed positive on NP swab, no positive C swabs | Day 17 | Conjunctival hyperemia and chemosis | ||
Colavita et al. [24] | Case report; traveler from Wuhan to Italy | 1 | 65 | 1 | Positive on NP swab until day 20, positive on C swab on day 3 and day 27 | Initial | Bilateral conjunctivitis | ||
Cheema et al. [25] | Case report | 1 | 29 | 1 | Positive NP swab, weakly positive on conjunctival swab with retrospective testing | Initial | Unilateral conjunctivitis, photophobia, watery discharge progressively worsened to sore, swollen lid, mucoid discharge, and eventually vision impairment; SLE showed follicular conjunctivitis, 2+ hyperemia, and positive for lymphadenopathy | Oral valacyclovir and moxifloxacin drops in right eye | |
Daruich et al. [26] | Case study; Argentina | 1 | 27 | 1 | Positive NP swab | Day 1 | Foreign body sensation and redness of left eye; on exam unilateral eyelid edema, and moderate conjunctival hyperemia | Topical antihistamine and steroid | |
Khavandi et al. [27] | Case study | 1 | 65 | 1 | Positive NP swab twice | Initial | Burning eye and discharge; SLE showed mucoid discharge and follicular conjunctivitis | Oseltamivir and hydroxychloroquine | |
Salducci et al. [28] | Case study; Diamond cruise in Italy | 1 | 72 | 1 | Positive NP swab | Day 1 | Bilateral conjunctivitis and photophobia with serous secretions, chemosis, pseudo membranes of fibrin on tarsal conjunctiva; this was his only symptom | Cold compress, artificial tears, local antiviral ganciclovir gel | |
Zhou et al. [29] | Retrospective cohort; Wuhan, China | 67 patients |
Mean 35.7 (range 22–78) Patient with conjunctivitis: 48 |
1 | 63 confirmed positive on NP swab. Of these, 1 positive and 2 probable positive C swabs | Initial | Conjunctivitis | Resolved without treatment | The patient with conjunctivitis did not have positive RT-PCR result on C swab |
Sun et al. [30] | Cross-sectional; Tongji Hospital, China | 102 |
Mean 58.68 Patient with positive conjunctival swab: 29 |
2 | 72 positive on NP swab, 1 positive C swab | Initial | Conjunctivitis; on exam conjunctival congestion and watery discharges in both eyes with normal visual acuity, normal corneal epithelium, quiescent anterior chamber, and no tenderness or enlargement of the preauricular lymph node | ||
Xia et al. [31] | Prospective interventional case series study; Zhejiang University Hospital | 30 | 53 | 1 | 30 confirmed positive on NP swab, 1 patient positive for tear swab, C swab, and sputum sample | Within 3 days, which was total disease course length | Viral conjunctivitis with conjunctival congestion and aqueous secretion | ||
Atum et al. [32] | Prospective interventional case series; Sakarya University Education and Research Hospital | 40 | Mean 41.3 | 10 | All positive on NP swab, 3 positives on C swab | Not noted | Conjunctivitis | Of the 10 with conjunctivitis, only 1 had positive C swab | |
Lomi et al. [33] | Retrospective cross-sectional observational study; North India | 127 | Median 38.8 (range 5–73) | 8 with visible manifestation, 11 total with ocular complaints | All confirmed positive on NP swab |
Initial: 5 out of 11 Late onset: 6 out of 11 |
Conjunctival congestion: 7 bilateral, 1 unilateral Other complaints: burning sensation and tearing |
||
Chen et al. [34] | Case study; Shenzhen, China | 1 | 30 | 1 | Positive on C swab | Day 13 | Bilateral conjunctivitis; SLE showed bilateral acute follicular conjunctivitis | Ribavirin eye drop | |
Guo et al. [35] | Case report; First Affiliated Hospital of Zhejiang University | 1 | 53 | 1 | Positive C swab during unilateral presentation of L eye. Negative C swab during bilateral presentation | Day 10 | Unilateral L eye conjunctivitis lasted 6 days with complete resolution. Then, 5 days later the patient developed bilateral keratoconjunctivitis |
First time, the L eye was treated with levofloxacin hydrochloride drops and 0.1% sodium hyaluronate Second time, bilateral eyes treated with ganciclovir ophthalmic gel, levofloxacin hydrochloride drops, and 0.1% sodium hyaluronate drops with no resolution 0.1% fluorometholone drops resulted in complete resolution |
|
Marinho et al. [36] | Case series on retinal findings | 12 | Range 25–69 | 12 | 9 positive on NP swab, 2 positive for serum antibody | 11–33 days after symptom onset |
B-scan OCT: 12 patients with hyperreflective lesions at level of inner plexiform and ganglion cell layers Retinal fundoscopy: 4 patients with subtle CWS and microhemorrhages |
||
Landecho et al. [37] | Case series on retinal findings | 27 | Median 56 (with CWS) Median 61 (without CWS) | 6 | Post-COVID infection: All negative NP swab, positive serum antibody | 2 weeks following hospital discharge (mean 43 days after first symptom) | Retinal fundoscopy: CWS 5 unilateral, 1 bilateral | All patients were treated with prophylactic low molecular weight heparin during hospitalization |
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2, RT-PCR reverse transcription polymerase chain reaction test for RNA of virus, NP nasopharyngeal, C conjunctival, SLE slit lamp exam, CWS cotton wool spots, OCT ocular coherence tomography